On July 21, 2022, IQVIA reported Q2 revenue of $3.54 billion (an increase of 3% year-over-year and 7.1% growth at constant currency) on GAAP Diluted Earnings per Share (EPS) of $1.34.
Summary: IQVIA’s Q2 2022 revenue grew 3% as compared to the same period in 2021 owing to Research & Development Solutions (R&DS) quarterly bookings of over $2.6 billion of net new business. IQVIA had three reportable segments: Technology & Analytics Solutions (TAS), Research & Development Solutions (R&DS), and Contract Sales & Medical Solutions (CSMS).
The company reported a GAAP operating margin of 13% during Q2 2022, a year-over-year increase of 450 bps. On the bottom line, the company reported a GAAP Diluted EPS of $1.34, whereas the Non-GAAP earnings came to $2.44 per share.
Guidance:
IQVIA expectations for the full year 2022 -
For the Q3 2022 –
United States of America
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer